共查询到20条相似文献,搜索用时 171 毫秒
1.
2.
《精细与专用化学品》2011,19(8):3-3
(本刊讯)中科院大连化学物理研究所在铁催化[2+2+2]环加成反应合成吡啶化合物的研究中取得新进展,相关结果以通讯的形式发表在最近一期的《德国应用化学》上(Angew.Chem.Int.Ed.2011,50,7162-7166)。吡啶及其衍生物被广泛用作有机合成试剂或作为医药、农药的生产中间体。环加成反应构建吡啶化合物原子利用率高达100%,是构建吡啶单元最直接、最高效的方法。尽管科学界在这一领域里付出了长期的努力并开发出了诸如Co、Rh、Ru、Ni、Ti等金属催化体系,但从1876年至今,该领域 相似文献
3.
吡啶系列产品主要是指吡啶及其衍生物,吡啶衍生物又称吡啶碱(Pyridine bases)。吡啶是含一个氮原子的六元芳杂环。其衍生物主要是在其环上带上各种取代基形成的一系列化合物。其中应用价值较大的是吡啶及吡啶碱。它们是: 相似文献
4.
设计合成了一个四苯基乙烯衍生物Model-TPE,该化合物具有典型的聚集诱导发光(AIE)特性。1 HNMR、质谱以及高效液相色谱研究表明,有氧条件下Model-TPE经紫外光照射发生关环反应,生成二苯基取代菲衍生物,取代和未取代苯环侧关环反应得到异构体产物,提出了光氧化关环反应机理。本工作对TPE衍生物在发光及传感领域的应用有一定的指导意义。 相似文献
5.
6.
氯沙坦为口服非肽类血管紧张素Ⅱ受体拮抗剂,于1994年首次在瑞典上市,2004年获得美国食品与药物管理局(FDA)批准,近年来一直是临床治疗高血压的一线药物。氯沙坦由咪唑环片断(A)、苯环片断(B)和(C)以及四氮唑环片断(D)拼合而成。该文根据各片断的连接次序不同,将氯沙坦的合成策略分为以下5种:"(B+C)+D+A"策略,"(B+C)+A+D"策略,"(C+D)+B+A"策略,"(C+D)+(A+B)策略"和"(A+B)+C+D"策略。并以该5种策略为主线综述了氯沙坦自诞生至今的合成工艺研究进展。 相似文献
7.
《现代化工》2016,(8)
以脱氢枞酸为原料,依次通过酯化反应、乙酰化反应和四组分串联反应合成了11个新型含吡啶环的脱氢枞酸衍生物(化合物4a~4k)。利用FT-IR、1HNMR和ESI-MS对上述化合物进行了结构表征。采用四甲基偶氮唑蓝比色法(MTT比色法)测试了上述化合物对人体单纯疱疹病毒I型(HSV-1)的体外抗病毒活性。结果表明,该系列衍生物具有一定的抗病毒活性,对HSV-1的半数有效浓度EC50在10~25μmol/m L之间,化合物4g的抗病毒活性最强,其EC50为12.1μmol/m L。初步构效关系分析表明,将吡啶环结构引入到脱氢枞酸骨架中可以提高衍生物的抗病毒活性。 相似文献
8.
9.
10.
11.
12.
Akira Kasahara Taeko Izumi Hiroshi Yanai Satoshi Murakami Masayuki Takatori 《Journal of chemical technology and biotechnology (Oxford, Oxfordshire : 1986)》1986,36(12):562-564
There are many indole derivatives bearing carboxyl or methoxycarbonyl groups on the benzene ring and these often have patent physiological activities. Synthesis of these compounds usually starts from indoles having a halogen group at the desired position on an indole ring. We now report a facile synthesis of 4-, 5-, and 6-indolecarboxylic acids from 2-bromoaniline derivatives ( 1 ). The synthetic route is shown in Figure 1. 相似文献
13.
Katarina Grabrijan Nika Straek Stanislav Gobec 《International journal of molecular sciences》2022,23(1)
Monocyclic ß-lactams (azetidin-2-ones) exhibit a wide range of biological activities, the most important of which are antibacterial, anticancer, and cholesterol absorption inhibitory activities. The synthesis of decorated monocyclic ß-lactams is challenging because their ring is highly constrained and consequently reactive, which is also an important determinant of their biological activity. We present the optimized synthesis of orthogonally protected 3-amino-4-substituted monocyclic ß-lactams. Among several possible synthetic approaches, Staudinger cycloaddition proved to be the most promising method for initial ring formation, yielding monocyclic ß-lactams with different substituents at the C-4 position, a phthalimido-protected 3-amino group, and a (dimethoxy)benzyl protected ring nitrogen. Challenging deprotection methods were then investigated. Oxidative cleavage with cerium ammonium nitrate and ammonia-free Birch reduction was found to be most effective for selective removal of ring nitrogen protection. Hydrazine hydrate was used for deprotection of the phthalimido group, and the procedure had to be modified by the addition of HCl in the case of aromatic substituents at the C-4 position. The presented methods and the synthesized 3-amino-4-substituted monocyclic ß-lactam derivatives are an important step toward new ß-lactams with potential pharmacological activities. 相似文献
14.
Marie Stiborová Věra ?erná Michaela Moserová Iveta Mrízová Volker M. Arlt Eva Frei 《International journal of molecular sciences》2015,16(1):284-306
Ellipticine is a DNA-damaging agent acting as a prodrug whose pharmacological efficiencies and genotoxic side effects are dictated by activation with cytochrome P450 (CYP). Over the last decade we have gained extensive experience in using pure enzymes and various animal models that helped to identify CYPs metabolizing ellipticine. In this review we focus on comparison between the in vitro and in vivo studies and show a necessity of both approaches to obtain valid information on CYP enzymes contributing to ellipticine metabolism. Discrepancies were found between the CYP enzymes activating ellipticine to 13-hydroxy- and 12-hydroxyellipticine generating covalent DNA adducts and those detoxifying this drug to 9-hydroxy- and 7-hydroellipticine in vitro and in vivo. In vivo, formation of ellipticine-DNA adducts is dependent not only on expression levels of CYP3A, catalyzing ellipticine activation in vitro, but also on those of CYP1A that oxidize ellipticine in vitro mainly to the detoxification products. The finding showing that cytochrome b5 alters the ratio of ellipticine metabolites generated by CYP1A1/2 and 3A4 explained this paradox. Whereas the detoxification of ellipticine by CYP1A and 3A is either decreased or not changed by cytochrome b5, activation leading to ellipticine-DNA adducts increased considerably. We show that (I) the pharmacological effects of ellipticine mediated by covalent ellipticine-derived DNA adducts are dictated by expression levels of CYP1A, 3A and cytochrome b5, and its own potency to induce these enzymes in tumor tissues, (II) animal models, where levels of CYPs are either knocked out or induced are appropriate to identify CYPs metabolizing ellipticine in vivo, and (III) extrapolation from in vitro data to the situation in vivo is not always possible, confirming the need for these animal models. 相似文献
15.
Benita Wiatrak Tomasz Gbarowski Eddie Czwojdziski Kazimierz Gsiorowski Beata Tyliska 《International journal of molecular sciences》2022,23(11)
Ellipticine is an indole alkaloid with proven antitumor activity against various tumors in vitro and a diverse mechanism of action, which includes topoisomerase II inhibition, intercalation, and cell cycle impact. Olivacine—ellipticine’s isomer—shows similar properties. The objectives of this work were as follows: (a) to find a new path of olivacine synthesis, (b) to study the cytotoxic properties of olivacine and ellipticine in comparison to doxorubicin as well as their impact on the cell cycle, and (c) to investigate the cellular pharmacokinetics of the tested compounds to understand drug resistance in cancer cells better. SRB and MTT assays were used to study the anticancer activity of olivacine and ellipticine in vitro. Both compounds showed a cytotoxic effect on various cell lines, most notably on the doxorubicin-resistant LoVo/DX model, with olivacine’s cytotoxicity approximately three times higher than doxorubicin. Olivacine proved to be less effective against cancer cells and less cytotoxic to normal cells than ellipticine. Olivacine proved to have fluorescent properties. Microscopic observation of cells treated with olivacine showed the difference in sensitivity depending on the cell line, with A549 cells visibly affected by a much lower concentration of olivacine than normal NHDF cells. An increased percentage of cells in G0/G1 was observed after treatment with olivacine and ellipticine, suggesting an impact on cell cycle progression, potentially via higher p53 protein expression, which blocks the transition from G0/G1 to the S phase. Ellipticine induced apoptosis at a concentration as low as 1 μM. It has been proved that the tested compounds (ellipticine and olivacine) undergo lysosomal exocytosis. Reducing exocytosis is possible through the use of compounds that inhibit the activity of the proton pump. Olivacine and ellipticine exhibited diverse cytotoxicity against a panel of cancer cells. Analysis of the lysosomal exocytosis of olivacine and ellipticine shows the need to look for derivatives with comparable anticancer activity but reduced weak base character. 相似文献
16.
Spiroketals are key structural motifs found in diverse natural products with compelling biological activities. However, stereocontrolled synthetic access to spiroketals, independent of their inherent thermodynamic preferences, is a classical challenge in organic synthesis that has limited in-depth biological exploration of this intriguing class. Herein, we review our laboratory's efforts to advance the glycal epoxide approach to the stereocontrolled synthesis of spiroketals via kinetically controlled spirocyclization reactions. This work has provided new synthetic methodologies with applications in both diversity- and target-oriented synthesis, fundamental insights into structure and reactivity, and efficient access to spiroketal libraries and natural products for biological evaluation. 相似文献
17.
Pedro Molina Mateo Alajarin Carmen Lopez-Leonardo Jose Elguero 《Advanced Synthesis \u0026amp; Catalysis》1993,335(4):305-315
Aza Wittig-type reaction either of iminophosphoranes derived from N-aminoheterocycles or bis(iminophosphoranes) has been found to be an useful method for the synthesis of the four-membered ring 1,3-diazetidine. This account deals with the following cyclization reaction, reactivity and synthetic utility of this ring system and related compounds. 相似文献
18.
Studies from our laboratories on the paraherquamide, brevianamide, and asperparaline families of natural products are reviewed. It has been proposed that the unique core ring system that is common to this family of compounds arises by a biological intramolecular Diels-Alder cycloaddition reaction. Key biosynthetic studies are described, along with classical synthetic approaches as well as those inspired by Nature for the synthesis of these interesting molecules. 相似文献
19.
20.
Indoline alkaloids constitute a large class of natural products; their diverse and complex structures contribute to potent biological activities in a range of molecules. Designing an appropriate strategy for the total synthesis of indoline alkaloids is a difficult task that depends on being able to efficiently assemble the core architectures. The best strategies allow access to a variety of different indoline alkaloid structures in a minimum of steps. The cyclopropanation of simple olefins and the subsequent synthetic transformation of the resulting cyclopropyl intermediates has been intensively studied in recent decades. In contrast, the cyclopropanation of enamines, especially for the construction of complex nitrogen-containing ring systems, remained relatively unexplored. Previous success with the cyclopropanation of simple indoles to form stable indolylcyclopropanocarboxylates encouraged us to explore the assembly of indoline alkaloid skeletons with cyclopropanation as a key reaction. Theoretically, indolylcyclopropanocarboxylates are doubly activated by a vicinally substituted amino group and carboxyl group; that is, they are typical donor-acceptor cyclopropanes. Accordingly, they tend to yield an active iminium intermediate, which can undergo inter- and intramolecular nucleophilic reactions to form the core structure of indoline alkaloids with an expanded ring system. In this Account, we summarize our efforts to develop a cascade or stepwise reaction of cyclopropanation/ring-opening/iminium cyclization (the CRI reaction) on tryptamine derivatives for assembling indoline alkaloid skeletons. With the CRI approach, three types of indoline alkaloid skeletons have been efficiently constructed: (i) hexahydropyrrolo[2,3-b]indoline (type I), (ii) tetrahydro-9a,4a-iminoethano-9H-carbazole (type II), and (iii) tetrahydroquinolino[2,3-b]indoline (type III). The effects of substituents on tryptamine derivatives were carefully investigated for inter- and intramolecular CRI reactions during construction of type I and type II skeletons. These results provided a basis for the further design and synthesis of complex natural products containing nitrogen. The usefulness of the CRI reaction is well demonstrated by our total synthesis of structurally intriguing indoline alkaloids such as N-acetylardeemin, minfiensine, vincorine, and communesin F. In addition, we highlight advances by other groups in construction of the three types of skeletons as well as their total syntheses of these indoline alkaloids. Discussion of the total syntheses of these indoline alkaloids focuses on comparing the individual synthetic strategies for forming the ring systems embedded in the final products. We also describe the total synthesis of perophoramidine, which has the same type III skeleton as communesin F. The observation of a retro Diels-Alder reaction during our synthesis of communesin F inspired the hetero Diels-Alder reaction on which our total synthesis of perophoramidine was based. 相似文献